首页> 外文期刊>The Journal of rheumatology >Reversing myocardial microvascular disease in a patient with rheumatoid arthritis.
【24h】

Reversing myocardial microvascular disease in a patient with rheumatoid arthritis.

机译:类风湿关节炎患者的心肌微血管疾病逆转。

获取原文
获取原文并翻译 | 示例
           

摘要

Rheumatoid arthritis (RA) is associated with increased cardiovascular mortality. This is regarded as being due to accelerated coronary atherosclerosis. We describe a 62-year-old man with seropositive erosive RA and extraarticular manifestations but no history of cardiovascular disease. Noninvasive assessment of myocardial blood flow by adenosine stressed thallium scanning showed reversible ischemia and diffusely poor myocardial perfusion. Repeat assessment after intensive immunosuppression for rheumatoid vasculitis revealed resolution of the ischemic changes and generally increased myocardial perfusion. Coronary angiography revealed no significant atheroma, suggesting that myocardial microvascular disease was responsible for the ischemia. This may be an important determinant of cardiovascular outcome in RA, and this case indicated that it can be reversed with immunosuppression.
机译:类风湿关节炎(RA)与心血管疾病死亡率增加相关。这被认为是由于冠状动脉粥样硬化的加速。我们描述了一名62岁的男性,患有血清反应性糜烂性RA和关节外表现,但无心血管疾病史。腺苷应力th扫描的无创评估心肌血流显示缺血可逆和弥漫性心肌灌注差。在对类风湿性血管炎进行强力免疫抑制后进行重复评估,结果显示缺血性变化得以缓解,并且心肌灌注普遍增加。冠状动脉造影未发现明显的动脉粥样硬化,提示心肌微血管疾病是缺血的原因。这可能是RA中心血管预后的重要决定因素,该病例表明可以通过免疫抑制逆转。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号